Tokyo, September 16, 2014 - Astellas Pharma Inc. (TSE: 4503; Headquarters: Tokyo; President & CEO: Yoshihiko Hatanaka) announced that it has been selected for the fourth consecutive year for the Dow Jones Sustainability Asia Pacific Index (“DJSI Asia Pacific”), the Asia Pacific version of the Dow Jones Sustainability Index* (“DJSI”), one of the world’s premier indexes for Socially Responsible Investment (SRI).
The DJSI, jointly compiled by Dow Jones & Company of the United States and RobecoSAM AG of Switzerland is a leading SRI index which assesses and selects leading sustainability-driven companies in terms of economic, environmental, and social criteria.
Specifically designed for companies in the developed Asia Pacific markets including Japan, the DJSI Asia Pacific has selected 148 companies, including 65 Japanese companies, which are leading the way in terms of sustainability among the 600 companies in the region.
Astellas defines its CSR-based management as: A means through which we strive toward sustainable enhancement of enterprise value while remaining acutely aware of our social responsibilities and taking a broad view that considers business, society, and humanity so we can exist not merely as a market entity, but also as a valuable member of society. Astellas promotes this as the cornerstone of all its corporate activities. Astellas, as a global pharmaceutical company, will continue committing to fulfill its social responsibility by promoting further CSR-based management aspiring to achieve its raison d’être “contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.”
*Dow Jones Sustainability Asia Pacific Index URL：http://www.sustainability-indexes.com/